You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 12, December 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Alert me on articles by topic

Conjunctival Melanoma With a Positive Sentinel Lymph Node

Arch Ophthalmol. 2003;121:1779-1783.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Conjunctival melanoma is a rare tumor of the ocular surface, with an annual incidence of fewer than 5 cases per million residents of the United States and a 10-year mortality rate of about 30%.1-3 The standard management of conjunctival melanoma consists of local resection, with application of cryotherapy to the resection margins.4 There is currently no reliable method of predicting which patients will develop regional lymph node metastasis, although tumor thickness is associated with poorer prognosis and higher likelihood of metastatic disease.5 After resection of conjunctival tumors, patients are commonly observed clinically until overt clinical signs of metastasis develop. Once clinically detectable metastatic disease develops, the prognosis is poor.

The regional lymph nodes are thought to be the first site of metastasis for most patients with conjunctival melanoma.1-3 The reported frequency of regional lymph node metastasis secondary to conjunctival melanoma varies from 26% to 40%.2, 6 The histologic status of the . . . [Full Text of this Article]

Report of a Case.


Comment.
Bita Esmaeli, MD
Houston, Tex

David Reifler, MD
Grand Rapids, Mich

Victor G. Prieto, MD, PhD; M. Amir Ahmadi, MD; Lillie Hidaji, BA; Ebrahim Delpassand, MD; Merrick I. Ross, MD
Houston

Corresponding author and reprints: Bita Esmaeli, MD, Ophthalmology Section, Department of Plastic Surgery, Box 443, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (e-mail: besmaeli@mdanderson.org).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography
Esmaeli
Br. J. Ophthalmol. 2008;92:443-445.
FULL TEXT  

Sentinel Lymph Node Biopsy for Sebaceous Cell Carcinoma and Melanoma of the Ocular Adnexa
Ho et al.
Arch Otolaryngol Head Neck Surg 2007;133:820-826.
ABSTRACT | FULL TEXT  

Conjunctival Melanoma in The Netherlands: A Nationwide Study
Missotten et al.
IOVS 2005;46:75-82.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.